Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Imatinib interim therapy between chemotherapeutic cycles and in vivo purging prior to autologous stem cell transplantation, followed by maintenance therapy is a feasible treatment strategy in Philadelphia chromosome-positive acute lymphoblastic leukemia.

× No keyword cloud information.

7 in total

1. Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance).

Authors: Meir Wetzler; Dorothy Watson; Wendy Stock; Gregory Koval; Flora A Mulkey; Eva E Hoke; John M McCarty; William G Blum; Bayard L Powell; Guido Marcucci; Clara D Bloomfield; Charles A Linker; Richard A Larson
Journal: Haematologica Date: 2013-09-27 Impact factor: 9.941

Review 2. Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of imatinib treatment on remission induction and allogeneic stem cell transplantation.

Authors: Tibor Kovacsovics; Richard T Maziarz
Journal: Curr Oncol Rep Date: 2006-09 Impact factor: 5.075

Review 3. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors: A K Fielding; G A Zakout
Journal: Curr Hematol Malig Rep Date: 2013-06 Impact factor: 3.952

4. Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research.

Authors: M R Bishop; B R Logan; S Gandham; B J Bolwell; J-Y Cahn; H M Lazarus; M R Litzow; D I Marks; P H Wiernik; P L McCarthy; J A Russell; C B Miller; J Sierra; G Milone; A Keating; F R Loberiza; S Giralt; M M Horowitz; D J Weisdorf
Journal: Bone Marrow Transplant Date: 2007-12-17 Impact factor: 5.483

Imatinib interim therapy between chemotherapeutic cycles and in vivo purging prior to autologous stem cell transplantation, followed by maintenance therapy is a feasible treatment strategy in Philadelphia chromosome-positive acute lymphoblastic leukemia.

1. Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance).

Review 2. Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of imatinib treatment on remission induction and allogeneic stem cell transplantation.

Review 3. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.

4. Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research.

Review 5. Update on practical aspects of the treatment of chronic myeloid leukemia with imatinib mesylate.

Review 6. Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Adults.

Review 7. Optimizing autologous hematopoietic stem cell transplantation for acute leukemia.